316 related articles for article (PubMed ID: 27372911)
1. Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
Sledge DG; Webster J; Kiupel M
Vet J; 2016 Sep; 215():43-54. PubMed ID: 27372911
[TBL] [Abstract][Full Text] [Related]
2. Canine cutaneous and subcutaneous mast cell tumours: a narrative review.
Bellamy E; Berlato D
J Small Anim Pract; 2022 Jul; 63(7):497-511. PubMed ID: 34671978
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors.
Kiupel M; Camus M
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):819-836. PubMed ID: 31178200
[TBL] [Abstract][Full Text] [Related]
4. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
[TBL] [Abstract][Full Text] [Related]
5. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication.
Webster JD; Yuzbasiyan-Gurkan V; Miller RA; Kaneene JB; Kiupel M
Vet Pathol; 2007 May; 44(3):298-308. PubMed ID: 17491070
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous mastocytosis in 8 young dogs and review of literature.
Yang C; Bradley CW; Preziosi D; Mauldin EA
Vet Pathol; 2023 Nov; 60(6):849-856. PubMed ID: 37222130
[TBL] [Abstract][Full Text] [Related]
8. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
Aytemiz Danyer I; Gürel A
Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta-analysis.
Freytag JO; Queiroz MR; Govoni VM; Pereira IVA; Pulz LH; de Francisco Strefezzi R; Queiroga FL; Cogliati B
Vet Comp Oncol; 2021 Sep; 19(3):529-540. PubMed ID: 33724647
[TBL] [Abstract][Full Text] [Related]
13. Expression of Phosphorylated KIT in Canine Mast Cell Tumor.
Halsey CHC; Thamm DH; Weishaar KM; Burton JH; Charles JB; Gustafson DL; Avery AC; Ehrhart EJ
Vet Pathol; 2017 May; 54(3):387-394. PubMed ID: 28129097
[TBL] [Abstract][Full Text] [Related]
14. Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference.
Northrup NC; Howerth EW; Harmon BG; Brown CA; Carmicheal KP; Garcia AP; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Gieger TL
J Vet Diagn Invest; 2005 Nov; 17(6):561-4. PubMed ID: 16475514
[TBL] [Abstract][Full Text] [Related]
15. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
16. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
17. Canine subcutaneous mast cell tumour: diagnosis and prognosis.
Newman SJ; Mrkonjich L; Walker KK; Rohrbach BW
J Comp Pathol; 2007 May; 136(4):231-9. PubMed ID: 17399734
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
[TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.
Dobson JM; Scase TJ
J Small Anim Pract; 2007 Aug; 48(8):424-31. PubMed ID: 17559522
[TBL] [Abstract][Full Text] [Related]
20. Investigating Associations Between Proliferation Indices, C-kit, and Lymph Node Stage in Canine Mast Cell Tumors.
Krick EL; Kiupel M; Durham AC; Thaiwong T; Brown DC; Sorenmo KU
J Am Anim Hosp Assoc; 2017; 53(5):258-264. PubMed ID: 28792799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
